Q3 INTERIM REPORT July-Sept 2024

Mentice has received a €1,062,750 EUR order for simulation solutions from a top 20 global MedTech company

Mentice receives an order of 1,008,000 USD for simulation solutions from a world-leading MedTech company

Wednesday, October 4, 2023

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that a global healthcare technology leader has signed an agreement to acquire Mentice VIST® simulation solutions for 1,008,000 USD.

The order will be accounted for in the order book for the business area Medical Device Industry during the fourth quarter of 2023.

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB